About: Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1980

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1980 (uk) im Mai 1980 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1980 (ast) scientific article published on 01 May 1980 (en)
publication date	wds:Q72421613-7655195A-044A-4FE1-B663-5DCB314776DE
publication date	1980-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72421613-02652C8B-9E51-4418-97C0-F67613D19D07
language of work or name	English
author name string	wds:Q72421613-01D9759B-E32D-45B3-BA07-D0AC236FB532 wds:Q72421613-1582E9A3-DE36-4E55-BF61-0C98EFBCBAEC wds:Q72421613-3219849E-D501-4D4D-8944-28A8C228F958 wds:Q72421613-5A6DCF5C-481A-45D3-92DE-9E56A32679A9 wds:Q72421613-B5452127-C65C-4BF8-9D6B-852C86C6A5FE wds:Q72421613-F4C95F10-56B4-4570-BBDA-0675F4B27F4E
author name string	Korelitz BI Glass JL Sachar DB Pasternack BS Present DH Wisch N
rdfs:label	Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study (en) Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study (nl)
skos:prefLabel	Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study (en) Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study (nl)
name	Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study (en) Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study (nl)
title	wds:Q72421613-57AB373A-2805-4CA9-9481-51D568209325
title	Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study (en)
page(s)	wds:Q72421613-0EA57BEA-B587-458B-A688-1F646BD0710C
page(s)	981-987
instance of	wds:Q72421613-320A09D4-DA5F-45D6-AC3C-2F2B71BE2BDC
instance of	scholarly article
main subject	wds:Q72421613-F356EB21-C5A9-4C4D-8E16-C3428B960696
main subject	Crohn's disease
PubMed ID	wds:Q72421613-3F713AB8-BC95-4A9A-9370-C49692933269
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6102739
PubMed ID	6102739
published in	wds:Q72421613-0E80B3B8-A9F4-445B-9252-B651402CD686
published in	The New England Journal of Medicine
issue	wds:Q72421613-55E24EA2-43AF-4075-907D-7D1D34F615BE
volume	wds:Q72421613-F55BC9D2-6490-47B9-9C6E-FF2CF2965021
issue	18
volume	302
number of pages	wds:Q72421613-415DB2A6-0354-41E3-A94E-710DBC534FA6
number of pages	7 (xsd:decimal)
DOI	wds:Q72421613-8FDEF7BF-2706-44D4-825D-4BBC542529D2
DOI	http://dx.doi.org/10.1056/NEJM198005013021801
DOI	10.1056/NEJM198005013021801
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72421613
is cites work of	CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Crohn's fistula: current concepts in management Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics Infliximab in Crohn's disease: early and long-term treatment Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits? The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease A controlled double blind study of azathioprine in the management of Crohn's disease Clinical pharmacology and pharmacogenetics of thiopurines Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Therapy of inflammatory bowel disease. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine The clinical pharmacology of 6-mercaptopurine AGA technical review on perianal Crohn’s disease Risk factors for surgery and postoperative recurrence in Crohn's disease. Inflammatory bowel disease in the pregnant woman Inflammatory bowel disease and pregnancy Methotrexate in patients with Crohn's disease after 6-mercaptopurine Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease Perianal Crohn's disease Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease Thiopurines in inflammatory bowel disease revisited Inflammatory bowel disease. Medical therapy of specific clinical presentations Managing Perianal Crohn’s Disease Inflammatory bowel disease Treatment of inflammatory bowel disease: a review of medical therapy Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel Disease Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy Newer treatments for inflammatory bowel disease Low-dose oral methotrexate in refractory inflammatory bowel disease Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine Olsalazine and 6-mercaptopurine-related bone marrow suppression: a possible drug-drug interaction Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: a review Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software